Stock FAQs

what is sens stock

by Dr. Wilfredo Krajcik Published 3 years ago Updated 2 years ago
image

What is senseonics'(Sens) stock price?

Apr 08, 2022 · Real-time trade and investing ideas on Senseonics Holdings SENS from the largest community of traders and investors.

Where can I buy SENs shares?

Get the latest Senseonics Holdings Inc (SENS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Is Sens stock a speculative buy?

Apr 11, 2022 · Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS." How do I buy shares of Senseonics? Shares of SENS can be purchased through any online brokerage account.

What is senseonics'stock symbol?

Apr 07, 2022 · SENS Senseonics Holdings — Stock Price and Discussion | Stocktwits. Senseonics Holdings NYSEMkt Updated Mar 18, 2022 8:00 PM. SENS …

image

Is it good to buy SENS stock?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Senseonics stock.

What does SENS company do?

Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community.

What sector is SENS stock in?

Health CareKey DataLabelValueExchangeAMEXSectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus1 Year Target$3.0013 more rows

Why is SENS stock dropping?

What happened. Shares of Senseonics Holdings ( SENS -0.55% ) were sinking 14.3% as of 3:12 p.m. EDT on Thursday. The big drop came after the medical technology company announced the pricing of a public offering of its stock.Jul 18, 2019

Will SENS get FDA approval?

Senseonics (NYSE:SENS) announced today that the FDA approved its next-generation continuous glucose monitor system, which lasts up to half a year.Feb 11, 2022

Did SENS get FDA approval?

(NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the approval of the next-generation Eversense® E3 CGM System by the Food and Drug Administration (FDA).Feb 11, 2022

What is SENS news?

Stock Exchange News Service (SENS) The JSE offers a service that provides the user with access to company announcements such as mergers, take-overs, rights offers, capital issues, cautionaries - all of which have a direct impact on the movement in the market. This service is called Stock Exchange news Service.

How many shares does SENS have?

Share StatisticsAvg Vol (3 month) 313.61MShares Outstanding 5463.15MImplied Shares Outstanding 6N/AFloat 8333.03M% Held by Insiders 19.91%7 more rows

Is Senseonics a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currentl...

When is Senseonics' next earnings date?

Senseonics is scheduled to release its next quarterly earnings announcement on Wednesday, May 11th 2022. View our earnings forecast for Senseonics .

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) posted its earnings results on Tuesday, November, 9th. The company reported $0.08 earnings per share...

What guidance has Senseonics issued on next quarter's earnings?

Senseonics updated its FY 2022 earnings guidance on Friday, March, 18th. The company provided earnings per share (EPS) guidance of for the period....

What price target have analysts set for SENS?

3 brokers have issued 1-year price targets for Senseonics' shares. Their forecasts range from $3.00 to $6.00. On average, they anticipate Senseonic...

Who are Senseonics' key executives?

Senseonics' management team includes the following people: Timothy T. Goodnow , President, Chief Executive Officer & Director Mukul Jain , Chief...

Who are some of Senseonics' key competitors?

Some companies that are related to Senseonics include Mesa Laboratories (MLAB) , Hurco Companies (HURC) , Crawford United (CRAWA) , Hickok (HIC...

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC) , Advanced...

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

About Senseonics

Headlines

Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application.

Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions

SENS: Is Senseonics Holdings a Smart Investment in 2022? - StockNews.com

Sensonics: Despite FDA Approval, Expectations Are Too High, Says Raymond James

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Senseonics stock.

Diabetes device maker lands crucial FDA approval after a year of Covid delays

At long last, following a year of Covid delays, Sensonics (SENS) received the FDA’s nod of approval for its long-lasting continuous glucose monitoring system (CGM). The Diabetes device maker’s Eversense E3 (180-Day sensor) has now been given the go ahead and should be available to patients in the U.S.

Beck Mack & Oliver Llc Buys Black Knight Inc, RadNet Inc, Hilton Worldwide Holdings Inc, ..

The approval comes after regulators spent a year prioritizing work directly related to the Covid-19 pandemic.

Ridgecrest Wealth Partners, Llc Buys Salesforce. ..

New York, NY, based Investment company Beck Mack & Oliver Llc (Current Portfolio) buys Black Knight Inc, RadNet Inc, Hilton Worldwide Holdings Inc, Ashtead Group PLC, 1stdibs.com Inc, sells Teva Pharmaceutical Industries, Baxter International Inc, Discovery Inc, Armstrong World Industries Inc, Anheuser-Busch InBev SA/NV during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Beck Mack & Oliver Llc..

Guild Investment Management, Inc. Buys The Mosaic Co, ProShares S&P 500 Dividend ..

Investment company Ridgecrest Wealth Partners, Llc (Current Portfolio) buys Salesforce.com Inc, Applied Materials Inc, Vanguard Short-Term Inflation-Protected Securities, Vanguard Tax-Exempt Bond ETF, iShares Short-Term National Muni Bond ETF, sells SPDR Bloomberg 1-3 Month T-Bill ETF, Tesla Inc, Goldman Sachs Access Treasury 0-1 Year ETF, Franklin Liberty Short Duration U.S..

Senseonics Expects FDA Nod For Next-Gen Eversense Glucose Monitoring System In Coming Weeks

Los Angeles, CA, based Investment company Guild Investment Management, Inc.

Do Options Traders Know Something About Senseonics (SENS) Stock We Don't?

Issuing an operational update, Senseonics Holdings Inc (NYSE: SENS) said FDA review for the PMA supplement for the next generation Eversense 180-day CGM system is nearing completion. All queries raised have been answered, and an approval decision is expected in the coming weeks.

How much did Senseonics stock fall in 2021?

Investors need to pay close attention to for Senseonics (SENS) stock based on the movements in the options market lately.

What does it mean when the stock floor is broken at $2.95?

The Senseonics Holdings Inc stock price fell by -7.69% on the last day (Wednesday, 7th Jul 2021) from $3.38 to $3.12. and has now fallen 3 days in a row. During the day the stock fluctuated 9.03% from a day low at $3.10 to a day high of $3.38. The price has been going up and down for this period, and there has been a -10.34% loss for the last 2 weeks. Volume has increased on the last day by 6 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 17 million shares were bought and sold for approximately $54.16 million.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9